Regency Capital Management Inc.\DE

Position in IRD — Opus Genetics, Inc.

CIK 1863894 HONOLULU, HI

Position in IRD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$238,380

-$71,020 QoQ

Shares Held

58,000

-14.7% QoQ

Ownership

0.070%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#45

of 102 holders

Holding Since

Mar 2021

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Regency Capital Management Inc.\DE holds $4,218,259 across 3 Biotechnology names. IRD ranks #2 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AURA	Aura Biosciences, Inc.	540,395	$3,836,804
2	IRD	Opus Genetics, Inc. This page	58,000	$238,380
3	ZNTL	Zentalis Pharmaceuticals, Inc.	29,500	$143,075

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$238,380	58,000	-14.7%	Shares	Sole	2026-08-13
2026-03-31	$309,400	68,000	+47.8%	Shares	Sole	2026-05-05
2025-12-31	$92,460	46,000	—	Shares	Sole	2026-02-11
2021-12-31	$0	0	-100.0%	Shares	Sole	2022-02-03
2021-09-30	$77,250	15,000	0.0%	Shares	Sole	2021-11-09
2021-06-30	$79,200	15,000	-11.8%	Shares	Sole	2021-07-07
2021-03-31	$98,770	17,000	—	Shares	Sole	2021-05-25
No filing history on record for this holder in this stock.